- Stage 1 Multiple Myeloma
Overview
Multiple Myeloma Stage 1 is the earliest stage of the disease and is generally associated with a relatively favorable prognosis compared to later stages.
In Stage 1 of Multiple Myeloma, the following markers are typically observed:
- Low levels of beta-2 microglobulin (less than 3.5 mg/L)
- High levels of albumin (3.5 g/dL or more)
- Normal LDH (lactate dehydrogenase)
- No high-risk gene mutations present
What tests will I need and Why?
Blood and Imaging tests are done to understand your general health, confirm your diagnosis and determine your cancer stage.
A bone marrow biopsy is a procedure where a small sample of bone marrow is taken, usually from your hip bone, using a thin needle. This helps doctors examine your cells and identify the type of myeloma cells present. This information is important for finding the best treatment option for you.
If your treatment team has not already performed tests to determine your cancer’s features and stage, please ask your doctor when these tests will be performed.
Re-read this summary as needed and then tap, “Compare My Treatment Options Now“. Our unique Comparison Page will help you understand your FDA-approved treatment options including, who can help you pay for your treatment, where and how each is given and what side-effects you may experience.
Replay this Audio as often as needed and then take a look at our Commonly Searched Questions below.
Cancerresearchuk.org